Daily Digest: DocuSign in acquisition crosshairs; Financial giant to cut 20K jobs
January 12, 2024 at 11:24 AM EST
Meanwhile, Swiss drugmaker Novartis has backed away from its effort to acquire Cytokinetics, prompting the South San Francisco-based drug developer's shares to fall about 20% on Thursday.
